Medtronic plc
medical device company
MDT NYSE
ISIN IE00BTN1Y115 SEC CIK 1613103
Follow Medtronic
Weekly email: filings, results
Revenue, last quarter
$9.8B
+13.7% vs same quarter last year
Net income
$1.5B
+41.3% vs same quarter last year
EPS, diluted
$1.14
+40.7% vs same quarter last year
Operating cash flow
$1.8B
+64.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $36.4B | $4.8K |
| FY25 | $33.5B | $4.7K |
| FY24 | $32.4B | $3.7K |
| FY23 | $31.2B | $3.8K |
| FY22 | $31.7B | $5K |
| FY21 | $30.1B | $3.6B |
| FY20 | $28.9B | $4.8B |
| FY19 | $30.6B | $4.6B |
| FY18 | $30B | $3.1B |
| FY17 | $29.7B | $4B |
| FY16 | $28.8B | $3.5B |
| FY15 | $20.3B | $2.7B |
| FY14 | $17B | $3.1B |
| FY13 | $16.6B | $3.5B |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 65% | 17.8% | 0% |
| FY25 | 65.3% | 17.8% | 0% |
| FY24 | 65.3% | 15.9% | 0% |
| FY23 | 65.7% | 17.6% | 0% |
| FY22 | 68% | 18.2% | 0% |
| FY21 | 65.2% | 14.9% | 12% |
| FY20 | 67.4% | 16.6% | 16.6% |
| FY19 | 70% | 20.5% | 15.2% |
| FY18 | 69.8% | 22.2% | 10.4% |
| FY17 | 68.7% | 18.1% | 13.6% |
| FY16 | 68.3% | 18.6% | 12.3% |
| FY15 | 68.9% | 18.6% | 13.2% |
| FY14 | 74.5% | 22.4% | 18% |
| FY13 | 75.1% | 26.5% | 20.9% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | $5.4B |
| FY25 | $5.2B |
| FY24 | $5.2B |
| FY23 | $4.6B |
| FY22 | $6B |
| FY21 | $4.9B |
| FY20 | $6B |
| FY19 | $5.9B |
| FY18 | $3.6B |
| FY17 | $5.6B |
| FY16 | $4.2B |
| FY15 | $4.3B |
| FY14 | $4.6B |
| FY13 | $4.5B |
| FY12 | - |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY26 | $3.6B | $1B |
| FY25 | $3.6B | $3.2B |
| FY24 | $3.7B | $2.1B |
| FY23 | $3.6B | $645M |
| FY22 | $3.4B | $2.5B |
| FY21 | $3.1B | $652M |
| FY20 | $2.9B | $1.3B |
| FY19 | $2.7B | $2.9B |
| FY18 | $2.5B | $2.2B |
| FY17 | $2.4B | $3.5B |
| FY16 | $2.1B | $2.8B |
| FY15 | $1.3B | $1.9B |
| FY14 | $1.1B | $2.6B |
| FY13 | $1.1B | $1.2B |
| FY12 | - | - |
- Medtronic
- Healthcare median
Show the numbers
| Year | Medtronic | Healthcare median |
|---|---|---|
| FY26 | 0% | −11.1% |
| FY25 | 0% | −30.8% |
| FY24 | 0% | −47% |
| FY23 | 0% | −58% |
| FY22 | 0% | −80.4% |
| FY21 | 12% | −71.9% |
| FY20 | 16.6% | −62.2% |
| FY19 | 15.2% | −46.3% |
| FY18 | 10.4% | −49.6% |
| FY17 | 13.6% | −45.9% |
| FY16 | 12.3% | −36% |
| FY15 | 13.2% | −38.4% |
| FY14 | 18% | −35.5% |
| FY13 | 20.9% | −37.1% |
| FY12 | - | −29.1% |